ABT analyst estimates
Abbott (ABT) analyst ratings, the average price target and its range, and every firm's latest call.
ABT analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 23, 2026 | Wells Fargo | Abbott price target raised to $120 from $119 at Wells Fargo | $120.00 |
| Oct 23, 2026 | UBS | StoneX Reiterates Buy Rating on Abbott Labs (ABT) | $120.00 |
| Oct 22, 2026 | Robert W. Baird | Abbott price target raised to $123 from $121 at Baird | $123.00 |
| Oct 22, 2026 | Wells Fargo | Abbott price target raised to $119 from $112 at Wells Fargo | $119.00 |
| Oct 22, 2026 | BTIG | Abbott price target lowered to $125 from $134 at BTIG | $125.00 |
| Oct 16, 2026 | New Street | StoneX Reiterates Buy Rating on Abbott Labs (ABT) | $120.00 |
| Oct 6, 2026 | Barclays | Abbott initiated with an Overweight at Barclays | $120.00 |
| Oct 2, 2026 | Redburn Partners | Rothschild Redburn Upgrades Abbott Labs (ABT) to Buy | $127.00 |
| Aug 13, 2026 | Wolfe Research | Abbott upgraded to Outperform from Peer Perform at Wolfe Research | $130.00 |
| Jul 28, 2026 | UBS | Abbott price target lowered to $125 from $135 at UBS | $125.00 |
| Jul 20, 2026 | Benchmark Co. | Abbott Labs (ABT) Reiterated at Buy by Benchmark After Q2 Model Updates | $120.00 |
| Jul 17, 2026 | Piper Sandler | Abbott price target raised to $118 from $115 at Piper Sandler | $118.00 |
| Jul 16, 2026 | BTIG | Abbott Labs (ABT) PT Raised to $134 at BTIGMember Login | $134.00 |
| Jul 6, 2026 | Evercore ISI | Abbott price target lowered to $112 from $120 at Evercore ISI | $112.00 |
| Jun 30, 2026 | Robert W. Baird | Abbott initiated with an Outperform at Baird | $121.00 |
- 20 firms rate ABT: 19 buy, 1 hold, 0 sell.
- The average price target is $121.36 from 11 analysts, from $112.00 to $130.00.
Updated 2026-11-02 17:51 UTC